Harmony Biosciences Holdings (HRMY) EBIT (2019 - 2026)
Harmony Biosciences Holdings' EBIT came in at $89.32 million for Q2 2026, up 85.4% from $48.18 million a year earlier and up 139.5% from the prior quarter.
Harmony Biosciences Holdings (HRMY) EBIT (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Harmony Biosciences Holdings reported EBIT of $230.65 million, up 4.0% year-over-year; for FY2025, it was $208.47 million, up 9.2% from FY2024.
- EBIT carries a five-year compound annual growth rate of 65.1% (FY2020 to FY2025).
- Going back by year, EBIT was $190.83 million in FY2024 (-0.6%), $192.03 million in FY2023 (+59.8%), $120.19 million in FY2022 (+37.3%) and $87.53 million in FY2021 (+415.3%).
- The Q2 2026 figure represents the highest quarterly EBIT in data going back to Q3 2019.
- Year-over-year, EBIT increased in five of the last eight quarters, with growth averaging 24.4%.
- The fastest year-over-year change in EBIT over five years came in Q3 2023 (growth of 442.0%), and the weakest in Q2 2024 (a decline of 54.5%).
- Business Quant data shows HRMY's EBIT at $37.29 million (Q1 2026), $38.56 million (Q4 2025) and $65.49 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Harmony Biosciences Holdings | 2.33 Bn | -431.22 Mn | 198.08 Mn | 89.32 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 89.32 Mn |
| Mar 31, 2026 | 37.29 Mn |
| Dec 31, 2025 | 38.56 Mn |
| Sep 30, 2025 | 65.49 Mn |
| Jun 30, 2025 | 48.18 Mn |
| Mar 31, 2025 | 56.25 Mn |
| Dec 31, 2024 | 55.73 Mn |
| Sep 30, 2024 | 61.71 Mn |
| Jun 30, 2024 | 21.36 Mn |
| Mar 31, 2024 | 52.03 Mn |
| Dec 31, 2023 | 40.20 Mn |
| Sep 30, 2023 | 64.51 Mn |
| Jun 30, 2023 | 46.90 Mn |
| Mar 31, 2023 | 40.42 Mn |
| Dec 31, 2022 | 47.61 Mn |
| Sep 30, 2022 | 11.90 Mn |
| Jun 30, 2022 | 33.12 Mn |
| Mar 31, 2022 | 27.56 Mn |
| Dec 31, 2021 | 28.63 Mn |
| Sep 30, 2021 | 21.05 Mn |
Harmony Biosciences Holdings EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=HRMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "HRMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=HRMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();